{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T23:07:18Z","timestamp":1793747238616,"version":"4.6.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"JSPS KAKENHI","award":["23K07150 and JP20K08015"],"award-info":[{"award-number":["23K07150 and JP20K08015"]}]},{"name":"Cabinet Office BRIDGE (programs for bridging the gap between R&D and the ideal society","award":["23K07150 and JP20K08015"],"award-info":[{"award-number":["23K07150 and JP20K08015"]}]},{"name":"JST BOOST","award":["JPMJBS2426"],"award-info":[{"award-number":["JPMJBS2426"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Jpn J Radiol"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s11604-026-02006-5","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T04:04:16Z","timestamp":1779249856000},"page":"1685-1697","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of 2D and 3D nnU-Net models with two-label and three-label strategies for automatic segmentation and total metabolic tumor volume estimation of metastatic differentiated thyroid carcinoma on FDG-PET\/CT"],"prefix":"10.1007","volume":"44","author":[{"given":"Yingtong","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0036-8975","authenticated-orcid":false,"given":"Kenji","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junki","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rina","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohsuke","family":"Kudo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"2006_CR1","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/S0140-6736(23)00020-X","volume":"401","author":"DW Chen","year":"2023","unstructured":"Chen DW, Lang BHH, McLeod DSA, Newbold K, Haymart MR. Thyroid cancer. Lancet. 2023;401:1531\u201344. https:\/\/doi.org\/10.1016\/S0140-6736(23)00020-X.","journal-title":"Lancet"},{"key":"2006_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12020-023-03302-0","volume":"81","author":"AM Gonz\u00e1lez-Clavijo","year":"2023","unstructured":"Gonz\u00e1lez-Clavijo AM, Cuellar AA, Triana-Urrego J, Barrero JA, Fierro-Maya LF. Metastatic differentiated thyroid cancer: worst prognosis in patients with metachronous metastases. Endocrine. 2023;81:90\u20137. https:\/\/doi.org\/10.1007\/s12020-023-03302-0.","journal-title":"Endocrine"},{"key":"2006_CR3","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1016\/j.path.2019.07.001","volume":"12","author":"NA Cipriani","year":"2019","unstructured":"Cipriani NA. Prognostic parameters in differentiated thyroid carcinomas. Surg Pathol Clin. 2019;12:883\u2013900. https:\/\/doi.org\/10.1016\/j.path.2019.07.001.","journal-title":"Surg Pathol Clin"},{"key":"2006_CR4","doi-asserted-by":"publisher","first-page":"972","DOI":"10.21037\/tcr.2019.12.43","volume":"9","author":"S Wang","year":"2020","unstructured":"Wang S, Luo J, Zhong Z, Qi X, Liu T, Qin R, et al. Treatment and prognosis for patients with differentiated thyroid carcinoma bone metastases. Transl Cancer Res. 2020;9:972\u201382. https:\/\/doi.org\/10.21037\/tcr.2019.12.43.","journal-title":"Transl Cancer Res"},{"key":"2006_CR5","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.3390\/diagnostics11081430","volume":"11","author":"E Lodi Rizzini","year":"2021","unstructured":"Lodi Rizzini E, Repaci A, Tabacchi E, Zanoni L, Vicennati V, Cavicchi O, et al. Impact of 18F-FDG PET\/CT on clinical management of suspected radio-iodine refractory differentiated thyroid cancer (RAI-R-DTC). Diagnostics. 2021;11:1430. https:\/\/doi.org\/10.3390\/diagnostics11081430.","journal-title":"Diagnostics"},{"key":"2006_CR6","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1007\/s00259-014-2794-7","volume":"41","author":"S Morbelli","year":"2014","unstructured":"Morbelli S, Bagnasco M. Differentiated thyroid cancer incidentally detected by 18F-FDG PET\/CT: patient\u2019s future in a hot-spot? Eur J Nucl Med Mol Imaging. 2014;41:1479\u201381. https:\/\/doi.org\/10.1007\/s00259-014-2794-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"Suppl 1","key":"2006_CR7","doi-asserted-by":"publisher","first-page":"122S","DOI":"10.2967\/jnumed.108.057307","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: evolving considerations for PET response criteria in solid tumors. J Nucl Med. 2009;50(Suppl 1):122S-S150. https:\/\/doi.org\/10.2967\/jnumed.108.057307.","journal-title":"J Nucl Med"},{"key":"2006_CR8","doi-asserted-by":"publisher","first-page":"30","DOI":"10.2967\/jnumed.120.242412","volume":"62","author":"N Capobianco","year":"2021","unstructured":"Capobianco N, Meignan M, Cottereau AS, Vercellino L, Sibille L, Spottiswoode B, et al. Deep-learning 18F-FDG uptake classification enables total metabolic tumor volume estimation in diffuse large B-cell lymphoma. J Nucl Med. 2021;62:30\u20136. https:\/\/doi.org\/10.2967\/jnumed.120.242412.","journal-title":"J Nucl Med"},{"key":"2006_CR9","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s12149-022-01798-6","volume":"37","author":"J Takenaka","year":"2023","unstructured":"Takenaka J, Watanabe S, Abe T, Hirata K, Uchiyama Y, Kimura R, et al. Prognostic value of [18F]FDG-PET prior to [131I]MIBG treatment for pheochromocytoma and paraganglioma (PPGL). Ann Nucl Med. 2023;37:10\u20137. https:\/\/doi.org\/10.1007\/s12149-022-01798-6.","journal-title":"Ann Nucl Med"},{"key":"2006_CR10","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s12149-021-01664-x","volume":"35","author":"Y Uchiyama","year":"2021","unstructured":"Uchiyama Y, Hirata K, Watanabe S, Okamoto S, Shiga T, Okada K, et al. Development and validation of a prediction model based on the organ-based metabolic tumor volume on FDG-PET in patients with differentiated thyroid carcinoma. Ann Nucl Med. 2021;35:1223\u201331. https:\/\/doi.org\/10.1007\/s12149-021-01664-x.","journal-title":"Ann Nucl Med"},{"key":"2006_CR11","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41592-020-01008-z","volume":"18","author":"F Isensee","year":"2021","unstructured":"Isensee F, Jaeger PF, Kohl SAA, Petersen J, Maier-Hein KH. nnU-Net: a self-configuring method for deep learning-based biomedical image segmentation. Nat Methods. 2021;18:203\u201311. https:\/\/doi.org\/10.1038\/s41592-020-01008-z.","journal-title":"Nat Methods"},{"key":"2006_CR12","doi-asserted-by":"publisher","first-page":"1362","DOI":"10.1007\/s00259-020-05080-7","volume":"48","author":"P Blanc-Durand","year":"2021","unstructured":"Blanc-Durand P, J\u00e9gou S, Kanoun S, Berriolo-Riedinger A, Bodet-Milin C, Kraeber-Bod\u00e9r\u00e9 F, et al. Fully automatic segmentation of diffuse large B cell lymphoma lesions on 3D FDG-PET\/CT for total metabolic tumour volume prediction using a convolutional neural network. Eur J Nucl Med Mol Imaging. 2021;48:1362\u201370. https:\/\/doi.org\/10.1007\/s00259-020-05080-7.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2006_CR13","doi-asserted-by":"publisher","first-page":"4801","DOI":"10.1007\/s00330-022-08573-1","volume":"32","author":"C Jiang","year":"2022","unstructured":"Jiang C, Chen K, Teng Y, Ding C, Zhou Z, Gao Y, et al. Deep learning-based tumour segmentation and total metabolic tumour volume prediction in the prognosis of diffuse large B-cell lymphoma patients in 3D FDG-PET images. Eur Radiol. 2022;32:4801\u201312. https:\/\/doi.org\/10.1007\/s00330-022-08573-1.","journal-title":"Eur Radiol"},{"key":"2006_CR14","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1007\/s00259-023-06555-z","volume":"51","author":"E Jafari","year":"2024","unstructured":"Jafari E, Zarei A, Dadgar H, Keshavarz A, Manafi-Farid R, Rostami H, et al. A convolutional neural network-based system for fully automatic segmentation of whole-body [68Ga]Ga-PSMA PET images in prostate cancer. Eur J Nucl Med Mol Imaging. 2024;51:1476\u201387. https:\/\/doi.org\/10.1007\/s00259-023-06555-z.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2006_CR15","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ad4300","author":"Y Yuan","year":"2024","unstructured":"Yuan Y, Tan W, Xu L, Bao N, Zhu Q, Wang Z, et al. An end-to-end multi-scale airway segmentation framework based on pulmonary CT image. Phys Med Biol. 2024. https:\/\/doi.org\/10.1088\/1361-6560\/ad4300.","journal-title":"Phys Med Biol"},{"key":"2006_CR16","doi-asserted-by":"publisher","DOI":"10.1007\/s10278-025-01646-9","author":"G Timpano","year":"2025","unstructured":"Timpano G, Veltri P, Vizza P, Cascini GL, Manti F. Deep learning-based 3D and 2D approaches for skeletal muscle segmentation on low-dose CT images. J Imaging Inform Med. 2025. https:\/\/doi.org\/10.1007\/s10278-025-01646-9.","journal-title":"J Imaging Inform Med"},{"key":"2006_CR17","doi-asserted-by":"publisher","first-page":"6858","DOI":"10.1007\/s00330-020-07011-4","volume":"30","author":"J Ren","year":"2020","unstructured":"Ren J, Yuan Y, Qi M, Tao X. Machine learning-based CT texture analysis to predict HPV status in oropharyngeal squamous cell carcinoma: comparison of 2D and 3D segmentation. Eur Radiol. 2020;30:6858\u201366. https:\/\/doi.org\/10.1007\/s00330-020-07011-4.","journal-title":"Eur Radiol"},{"key":"2006_CR18","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.ultrasmedbio.2022.09.017","volume":"49","author":"C Li","year":"2023","unstructured":"Li C, Du R, Luo Q, Wang R, Ding X. A novel model of thyroid nodule segmentation for ultrasound images. Ultrasound Med Biol. 2023;49:489\u201396. https:\/\/doi.org\/10.1016\/j.ultrasmedbio.2022.09.017.","journal-title":"Ultrasound Med Biol"},{"key":"2006_CR19","doi-asserted-by":"publisher","unstructured":"Kalisch H, H\u00f6rst F, Herrmann K, Kleesiek J, Seibold C. AutoPET III challenge: incorporating anatomical knowledge into nnU-Net for lesion segmentation in PET\/CT. arXiv [Preprint]. 2024. https:\/\/doi.org\/10.48550\/arXiv.2409.12155.","DOI":"10.48550\/arXiv.2409.12155"},{"key":"2006_CR20","doi-asserted-by":"publisher","first-page":"e105682","DOI":"10.1371\/journal.pone.0105682","volume":"9","author":"K Hirata","year":"2014","unstructured":"Hirata K, Kobayashi K, Wong KP, Manabe O, Surmak A, Tamaki N, et al. A semi-automated technique determining the liver standardized uptake value reference for tumor delineation in FDG PET-CT. PLoS ONE. 2014;9:e105682. https:\/\/doi.org\/10.1371\/journal.pone.0105682.","journal-title":"PLoS ONE"},{"key":"2006_CR21","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1007\/s13246-023-01258-z","volume":"46","author":"R Nigam","year":"2023","unstructured":"Nigam R, Field M, Harris G, Barton M, Carolan M, Metcalfe P, et al. Automated detection, delineation and quantification of whole-body bone metastasis using FDG-PET\/CT images. Phys Eng Sci Med. 2023;46:851\u201363. https:\/\/doi.org\/10.1007\/s13246-023-01258-z.","journal-title":"Phys Eng Sci Med"},{"key":"2006_CR22","doi-asserted-by":"publisher","unstructured":"Rokuss M, Kovacs B, Kirchhoff Y, Xiao S, Ulrich C, Maier-Hein KH, et al. From FDG to PSMA: A Hitchhiker\u2019s Guide to Multitracer, Multicenter Lesion Segmentation in PET\/CT Imaging. arXiv [preprint]. 2024. arXiv:2409.09478. https:\/\/doi.org\/10.48550\/arXiv.2409.09487.","DOI":"10.48550\/arXiv.2409.09487"},{"key":"2006_CR23","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.2967\/jnumed.125.270077","volume":"66","author":"P Jackson","year":"2025","unstructured":"Jackson P, Buteau JP, McIntosh L, et al. Deep learning for automated measures of SUV and molecular tumor volume in [68Ga]PSMA-11 or [18F]DCFPyL, [18F]FDG, and [177Lu]Lu-PSMA-617 imaging with global threshold regional consensus network. J Nucl Med. 2025;66:1811\u20137. https:\/\/doi.org\/10.2967\/jnumed.125.270077.","journal-title":"J Nucl Med"},{"key":"2006_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.2967\/jnumed.123.267048","volume":"65","author":"KH Leung","year":"2024","unstructured":"Leung KH, Rowe SP, Sadaghiani MS, Leal JP, Mena E, Choyke PL, et al. Deep semisupervised transfer learning for fully automated whole-body tumor quantification and prognosis of cancer on PET\/CT. J Nucl Med. 2024;65:643\u201350. https:\/\/doi.org\/10.2967\/jnumed.123.267048.","journal-title":"J Nucl Med"},{"key":"2006_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s13014-024-02491-w","volume":"19","author":"JC Holzschuh","year":"2024","unstructured":"Holzschuh JC, Mix M, Freitag MT, H\u00f6lscher T, Braune A, Kotzerke J, et al. The impact of multicentric datasets for the automated tumor delineation in primary prostate cancer using convolutional neural networks on 18F-PSMA-1007 PET. Radiat Oncol. 2024;19:106. https:\/\/doi.org\/10.1186\/s13014-024-02491-w.","journal-title":"Radiat Oncol"},{"key":"2006_CR26","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s00259-022-05927-1","volume":"50","author":"J Kendrick","year":"2022","unstructured":"Kendrick J, Francis RJ, Hassan GM, Rowshanfarzad P, Ong JSL, Ebert MA. Fully automatic prognostic biomarker extraction from metastatic prostate lesion segmentations in whole-body [68Ga]Ga-PSMA-11 PET\/CT images. Eur J Nucl Med Mol Imaging. 2022;50:67\u201379. https:\/\/doi.org\/10.1007\/s00259-022-05927-1.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"2006_CR27","doi-asserted-by":"publisher","first-page":"888","DOI":"10.1007\/s10278-020-00341-1","volume":"33","author":"S Jemaa","year":"2020","unstructured":"Jemaa S, Fredrickson J, Carano RAD, Nielsen T, de Crespigny A, Bengtsson T. Tumor segmentation and feature extraction from whole-body FDG-PET\/CT using cascaded 2D and 3D convolutional neural networks. J Digit Imaging. 2020;33:888\u201394. https:\/\/doi.org\/10.1007\/s10278-020-00341-1.","journal-title":"J Digit Imaging"},{"issue":"12603","key":"2006_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/978-3-030-67194-5_10","volume":"2021","author":"MA Naser","year":"2020","unstructured":"Naser MA, van Dijk LV, He R, Wahid KA, Fuller CD. Tumor segmentation in patients with head and neck cancers using deep learning based-on multi-modality PET\/CT Images. Head Neck Tumor Segm. 2020;2021(12603):85\u201398. https:\/\/doi.org\/10.1007\/978-3-030-67194-5_10.","journal-title":"Head Neck Tumor Segm"},{"key":"2006_CR29","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1097\/RLU.0000000000000780","volume":"40","author":"S Masson-Deshayes","year":"2015","unstructured":"Masson-Deshayes S, Schvartz C, Dalban C, Guendouzen S, Pochart JM, Dalac A, et al. Prognostic value of (18)F-FDG PET\/CT metabolic parameters in metastatic differentiated thyroid cancers. Clin Nucl Med. 2015;40:469\u201375. https:\/\/doi.org\/10.1097\/RLU.0000000000000780.","journal-title":"Clin Nucl Med"}],"container-title":["Japanese Journal of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-026-02006-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11604-026-02006-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11604-026-02006-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T05:17:27Z","timestamp":1787980647000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11604-026-02006-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":29,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2006"],"URL":"https:\/\/doi.org\/10.1007\/s11604-026-02006-5","relation":{},"ISSN":["1867-1071","1867-108X"],"issn-type":[{"value":"1867-1071","type":"print"},{"value":"1867-108X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"assertion":[{"value":"14 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"KH received joint research fundings from GE HealthCare Japan Corporation, Sumitomo Heavy Industries, Ltd., and Nihon Medi-Physics Co., Ltd. Additionally, KH received clinical trial-related funding from Novartis Pharma K.K.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Institutional Review Board of Hokkaido University Hospital (approval number: 020-0315). All procedures were conducted in accordance with the principles of the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The requirement for written informed consent was waived because of the retrospective design.","order":3,"name":"Ethics","label":"Informed consent","group":{"name":"EthicsHeading","label":"Declarations"}}]}}